[SYRE] YoY Quarter Result on 31-Mar-2021 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 19.79%
YoY- 2.72%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 198 1,362 0 0 0 1,510 -
PBT -43,825 -18,458 -24,436 -18,218 -18,728 -17,167 -8,119 32.41%
Tax -32 -36 0 0 0 0 0 -
NP -43,857 -18,422 -24,436 -18,218 -18,728 -17,167 -8,119 32.42%
Tax Rate - - - - - - - -
Total Cost 43,857 18,620 25,798 18,218 18,728 17,167 9,629 28.71%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 -9,304.04 -1,794.13 0.00 0.00 0.00 -537.68 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -1.20 -4.89 -9.26 -6.94 -14.15 -14.79 -12.17 -32.00%
EPS Diluted -1.20 -4.89 -9.26 -6.94 -14.15 -14.79 -12.17 -32.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.